ADAR1 Capital Management »

Tyra Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.8k 300 15.99
2024-03-31 $464k 28k 16.40

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Tyra Biosciences

RA Capital Management
Canaan Partners XI
Alta Partners Management Company
Nextech Invest
BVF
FMR
Boxer Capital Management
TCG Crossover Management
Henderson Group
BlackRock
OrbiMed Advisors
Vanguard Group
Farallon Capital Management
5AM Venture Management
Geode Capital Management

View all funds holding Tyra Biosciences